Monitoring health data remotely to predict COPD flare-ups
Physiological and Environmental Data in a Remote Setting to Predict Exacerbation Events in Patients With Chronic Obstructive Pulmonary Disease
Chelsea and Westminster NHS Foundation Trust · NCT06118632
This study tests whether using a smartphone app and Fitbit can help people with COPD spot early warning signs of flare-ups after leaving the hospital.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years to 120 Years |
| Sex | All |
| Sponsor | Chelsea and Westminster NHS Foundation Trust (other) |
| Locations | 4 sites (Aylesbury and 3 other locations) |
| Trial ID | NCT06118632 on ClinicalTrials.gov |
What this trial studies
This study monitors approximately 300 patients with Chronic Obstructive Pulmonary Disease (COPD) for three months after hospital discharge using a smartphone app and Fitbit device. The aim is to collect ongoing physiological data to identify early warning signs of health decline and exacerbation events. By analyzing these measurements in real-world settings, the research team hopes to understand the impact of environmental factors on patient health. This approach could enable timely medical interventions to prevent further deterioration and hospital admissions.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and over with a diagnosis of COPD who are clinically stable after an acute exacerbation and own a compatible smartphone.
Not a fit: Patients who are not clinically stable, require non-invasive ventilation, or have a life expectancy of less than 90 days post-discharge may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier interventions for COPD patients, potentially reducing hospital admissions and improving quality of life.
How similar studies have performed: While the approach of using remote monitoring for COPD is gaining traction, this specific methodology of combining smartphone and wearable technology in a real-world setting is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 18 or over. * Diagnosis of COPD, currently admitted to hospital and clinically stable with a confirmed acute exacerbation of COPD. * Ownership of a smartphone (iOS version 13 or above, Android version 8 or above). * Able to provide informed consent to participate in study. Exclusion Criteria: * Patients who require less than 24 hours in hospital at initial visit. * Patients deemed unlikely to cooperate with study requirements. * Patients with implantable devices. * Patient not felt to be suitable for research enrolment by admitting clinical team. * Patients requiring non-invasive ventilation or deemed to have a life-expectancy of less than 90 days following discharge.
Where this trial is running
Aylesbury and 3 other locations
- Stoke Mandeville Hospital — Aylesbury, United Kingdom (RECRUITING)
- Royal Sussex County Hospital — Brighton, United Kingdom (RECRUITING)
- Chelsea and Westminster Hospital NHS Foundation Trust — London, United Kingdom (RECRUITING)
- Nottingham University Hospitals — Nottingham, United Kingdom (RECRUITING)
Study contacts
- Study coordinator: Arnold Xhikola
- Email: arnold.xhikola1@nhs.net
- Phone: 00442033152560
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COPD Exacerbation